The Patent Finder

Terms ending in 2033

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,919,950Expression Vector Encoding Antibody Molecule Which Binds IL-17A and IL-17F
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
US 10,221,251Sequence Symmetric Modified IGG4 Bispecific Antibodies
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
US 10,562,966Antibodies of the Class IGG4
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
US 9,803,004Albumin Binding Antibodies and Binding Fragments Thereof
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
US 11,466,324Lipocalin 2 as a Biomarker for IL-17 Inhibitor Therapy Efficacy
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
US 9,808,575Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 10,799,583Treatment for Bone Diseases
In force
 · Medium confidence
Ucb Pharma, S.A.In forceMedium confidence
US 12,667,615Treatment for Bone Diseases
In force
 · Medium confidence
Ucb Pharma S.A.In forceMedium confidence
US 9,795,734Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 11,059,911Sequence Symmetric Modified IGG4 Bispecific Antibodies
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
4 more term ends in 2033 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
3 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited